Pall-ATMI LifeSciences

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Nov 25, 2014	Promethera Biosciences	$25.4M Series C	Boehringer Ingelheim, Vesalius Biocapital	Mitsui & Co. Global Investment, SFPI-FPIM, Shire, SMS Investments, SRIW, VIVES Louvain Technology Fund

Total Raised

N/A

Valuation

N/A